RonaldNewcomb

PACB on a long ramp up

Длинная
NASDAQ:PACB   Pacific Biosciences of California, Inc.
Great company with a good competitive product revealed a breakthrough in genetic sequencing long awaited by the early investors who paid $16 for their positions as can be seen in this weekly chart (upper left). They believe it is worth that, risk adjusted, so, likely in the $25 range if successful. They were. Sustainable lead is a critical new study field, gene sequencing with an affordable fast long sequence machine.
Motley Fool recommended as a long term hold, at $14.
Buy signal from the CM_Ultimate_MA was at $4.50, entered at $4.76, then again at $7.00. Considering adding to the position as it breaks resistance then pulls back.
Отказ от ответственности

Все виды контента, которые вы можете увидеть на TradingView, не являются финансовыми, инвестиционными, торговыми или любыми другими рекомендациями. Мы не предоставляем советы по покупке и продаже активов. Подробнее — в Условиях использования TradingView.